All Stories

  1. Bioactive factors secreted by Bifidobacterium breve B-3 enhance barrier function in human intestinal Caco-2 cells
  2. Lysozyme in breast milk is a selection factor for bifidobacterial colonisation in the infant intestine
  3. Oral administration of Bifidobacterium breve B-3 modifies metabolic functions in adults with obese tendencies in a randomised controlled trial